These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Current status, strategies, and potential for the metabolic engineering of heterologous polyketides in Escherichia coli.
    Author: Boghigian BA, Pfeifer BA.
    Journal: Biotechnol Lett; 2008 Aug; 30(8):1323-30. PubMed ID: 18488149.
    Abstract:
    Heterologous natural product biosynthesis has emerged as a strategy to produce medicinal compounds that pose challenges to conventional production routes. Polyketide compounds, an important class of natural products with wide-ranging therapeutic value, have been heterologously produced through Escherichia coli, presenting new opportunities to realize the medicinal potential of polyketide natural products. However, current production levels are often suboptimal when compared to native strain producers or heterologous theoretical yields. This problem provides an excellent opportunity to apply and further develop current metabolic engineering tools.
    [Abstract] [Full Text] [Related] [New Search]